RFI S-44000-00015479_Clinician Advisory Services.pdf

RFI S-44000-00015479

Clinician Advisory Services Page 1 of 4

Department of Consumer and Business Services Central Services Division, Procurement Section

350 Winter Street NE Salem, OR 97301

REQUEST FOR INFORMATION (RFI)

CLINICIAN ADVISORY SERVICES

RFI #S-44000-00015479

***THIS IS NOT AN ORDER***

Submit your information by 2:00PM Pacific Time on January 30, 2026 via email to:

Single Point of Contact (SPC): Daniel Robinson, Procurement Specialist 350 Winter Street NE, Room 2 Salem, OR 97301

(503) 302-9747 Email Questions: daniel.k.robinson@dcbs.oregon.gov

1. Overview

This request for information (RFI) is issued by the State of Oregon, Department of Consumer and Business Services, Central Services Division (Agency) to seek information regarding clinician support for the Oregon Prescription Drug Affordability Board to consider.

This RFI is NOT a solicitation for quotes, bids or proposals. Responses provided to this RFI will be used only for general information purposes and will not be considered binding by any party. Responses provided to this RFI will be analyzed and may be used to develop a subsequent solicitation. However, responses will not have any impact on any solicitation selection process. No Contracts or Agreements will be awarded as a result of this RFI.

This RFI is designed to provide respondents with the information and criteria that Agency has determined to be the most relevant and essential. It is not intended to limit any other information that a respondent deems important.

All costs incurred in preparing and submitting a response to this RFI will be the responsibility of the submitter and will not be reimbursed by the State of Oregon.

Clinician Advisory Services Page 2 of 4

2. Background

The Department of Consumer and Business Services (DCBS) is Oregon’s largest regulatory and consumer protection agency. It administers state laws and rules, protects consumers and workers in the areas of workers’ compensation, occupational safety and health, financial services, insurance and building codes.

The Division of Financial Regulation (DFR) is a division of DCBS and oversees the financial and insurance industries in Oregon. It regulates insurance, depository institutions, trust companies, securities and consumer financial products and services. (e.g., mortgage lending, small dollar loans, collection agencies).

The Oregon Legislature established the Prescription Drug Affordability Board (“Board”) in 2021 through Senate Bill 844, and Board members began meeting in June 2022. The purpose of the board is to protect residents of Oregon, state and local governments, commercial health plans, health care providers, pharmacies licensed in Oregon, and other stakeholders within the health care system from the high costs of prescription drugs. The Board is established and supported within DFR and has a legislatively mandated business need to identify price concessions, discounts, and rebates that drug manufacturers provide to pharmacy benefit managers.

3. Issues and Needs

The Board and Agency are looking for ongoing clinical advisory services to support the Agency’s Board staff, as well as the members of the Drug Pricing Transparency Program, to focus on the applicability and details of drugs that are part of the legislatively mandated Board affordability reviews.

4. Objectives

The objective of this RFI is to:

a. Nature of work: Identify vendors/consultants to perform the following work:

i. Provide Agency staff clinical advisory services in support of prescription drugs that are considered and selected as part of affordability reviews. This includes:

a. Attend meetings scheduled by Agency

b. Communicate in a timely manner with staff (one business day response by text or email)

c. Create supporting documents as requested by Agency.

d. Review and provide feedback on documents created by Agency, within the deadline provided.

https://olis.oregonlegislature.gov/liz/2021R1/Downloads/MeasureDocument/SB844/Enrolled

Clinician Advisory Services Page 3 of 4

ii. Provide Agency estimated work hours and rate for any documentation development or review before beginning work.

iii. Provide program development consultation to Agency staff as requested.

b. Deliverables: Contractor shall provide ongoing clinical advisory services to Agency staff and Agency-identified stakeholders, focused on the applicability and details of drugs that are part of the legislatively mandated Board affordability reviews. Deliverables will be assigned by Agency on an as needed basis and may include the following data for drugs under affordability/cost review:

i. Developing a clinical profile that includes drug indications, dosing, clinical efficacy, clinical safety, and therapeutic alternatives.

ii. For specific prescription drugs under review as well as any therapeutic alternatives, confirm dose, frequency, National Drug Code (NDC), route of administration, dosage form, strength and/or strength of measure.

iii. Other additional or related information requested regarding drug under review or therapeutic equivalents.

5. Minimum Qualifications

Offeror must submit resumes for key person(s). At a least one key person must have a Doctor of Pharmacy (PharmD) degree and is using it professionally.

Agency reserves the right to determine whether Offeror and Offeror’s assigned examiners meet the minimum qualifications.

6. Requested information

a. Confirm PharmD degree for you or staff.

b. Confirm if you have experience consulting for public entities (city, county, state, federal) and any clinical experience regarding drug reviews.

c. Provide insight into your process to complete Section 4 above (Objectives).

d. Availability to support the board.

e. Any potential conflicts of interest.

Clinician Advisory Services Page 4 of 4

7. RFI Schedule

Issued Date: December 19, 2025 Questions and Clarifications Due: January 14, 2026 @5:00 PM (PT) Answers to Questions and Clarifications Due: January 21, 2026 @ 5:00 PM(PT) Responses Due: January 30, 2026 @ 2:00 PM (PT)

8. RFI Submission Process

a. Single Point of Contact (SPC)

All communications, including questions, comments, and requests for clarification must be in writing to the SPC listed on the front page and emailed to (daniel.k.robinson@dcbs.oregon.gov).

b. Response Submissions

i. Responses shall be submitted in written form formatted as doc, docx, xls, xlsx or pdf .

ii. No verbal responses will be accepted.

iii. Agency is only accepting electronic submissions emailed to

DCBS.Opportunity@oregon.gov. The size limit for a single email is 10MB. You may submit a Response in one or more parts to ensure proper delivery.

iv. Email subject line must include “RFI S-44000-00015479”

v. Complete the Respondent Summary Page (Attachment A) and submit with RFI response.

vi. Responses must be received no later than January 30, 2026, 2:00PM Pacific Time

c. Public Records

The information received shall be kept by Agency and made a part of a file or record, which will be open to public inspection. If respondents believe any of its RFI response is exempt from disclosure under Oregon Public Records law (ORS 192.311 through 192.478), respondent shall complete and submit the Affidavit of Trade Secret (Attachment B) an submit a fully redacted version of its information, clearly identified as the redacted version.

Identifying the Response in whole as exempt from disclosure is not acceptable. If submitter fails to identify the portions of the Response which submitter claims are exempt from disclosure, submitter is deemed to have waived any future claim of non-disclosure of that information.

mailto:DCBS.Opportunity@oregon.gov